ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,463.47
      0.94%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Inventiva (IVA)

      7. Inventiva (IVA) News

      IVA

      Inventiva (IVA)

      Inventiva
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:IVA
      DateTimeSourceHeadlineSymbolCompany
      09/07/20224:00PMGlobeNewswire Inc.Inventiva announces the schedule of publication and presentation of its 2022 Half-Year Financial ResultsEU:IVAInventiva
      09/07/20224:00PMGlobeNewswire Inc.Inventiva annonce la date de publication et de présentation de ses résultats du 1 ͤ ͬ semestre 2022EU:IVAInventiva
      07/28/20224:00PMGlobeNewswire Inc.Inventiva publie ses informations financières du 1er semestre 2022¹EU:IVAInventiva
      07/28/20224:00PMGlobeNewswire Inc.Inventiva Reports 2022 First-Half Financial Information¹EU:IVAInventiva
      07/28/20224:00PMGlobeNewswire Inc.Inventiva Reports 2022 First-Half Financial Information¹EU:IVAInventiva
      07/21/202212:00PMGlobeNewswire Inc.Half-Year Review of Inventiva’s Liquidity Contract with Kepler CheuvreuxEU:IVAInventiva
      07/21/202212:00PMGlobeNewswire Inc.Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler CheuvreuxEU:IVAInventiva
      07/07/20224:00PMGlobeNewswire Inc.Inventiva annonce le screening du premier patient dans l’essai clinique de Phase IIa LEGEND combinant lanifibranor et empagliflozine chez des patients atteints de la NASH et de DT2EU:IVAInventiva
      07/07/20224:00PMGlobeNewswire Inc.Inventiva announces the screening of the first patient in LEGEND, a Phase IIa combination trial with lanifibranor and empagliflozin in patients with NASH and T2DEU:IVAInventiva
      07/04/202212:45PMGlobeNewswire Inc.Update on Inventiva's cash position and on the finance documentation with the European Investment BankEU:IVAInventiva
      07/04/202212:45PMGlobeNewswire Inc.Point sur la situation de trésorerie d'Inventiva et sur le crédit conclu avec la Banque Européenne d'InvestissementEU:IVAInventiva
      06/16/20224:00PMGlobeNewswire Inc.Inventiva to host a webcast with Key Opinion Leaders following the EASL International Liver Congress™ 2022EU:IVAInventiva
      06/16/20224:00PMGlobeNewswire Inc.Inventiva organise un webcast avec des leaders d’opinion à l’occasion de l’EASL International Liver Congress™ 2022EU:IVAInventiva
      06/09/20224:00PMGlobeNewswire Inc.Inventiva announces three scientific presentations at the EASL International Liver Congress™ 2022EU:IVAInventiva
      06/07/20224:00PMGlobeNewswire Inc. Inventiva intègre le segment Tech Leaders d’EuronextEU:IVAInventiva
      06/07/20224:00PMGlobeNewswire Inc.Inventiva joins the Euronext Tech Leaders segmentEU:IVAInventiva
      06/03/20224:00PMGlobeNewswire Inc. Inventiva annonce la présentation d’un abstract scientifique lors de la 82nd Scientific Sessions of the American Diabetes AssociationEU:IVAInventiva
      06/03/20224:00PMGlobeNewswire Inc. Inventiva announces the presentation of a scientific abstract at the 82nd Scientific Sessions of the American Diabetes AssociationEU:IVAInventiva
      05/23/20224:00PMGlobeNewswire Inc.Inventiva announces participation at several investors conferences in May and June 2022EU:IVAInventiva
      05/23/20224:00PMGlobeNewswire Inc.Inventiva annonce sa participation à plusieurs conférences investisseurs en mai et juin 2022EU:IVAInventiva
      05/20/20224:00PMGlobeNewswire Inc.Results of the votes of the Combined Shareholders’ Meeting of May 19, 2022EU:IVAInventiva
      05/20/20224:00PMGlobeNewswire Inc.Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunie le 19 mai 2022EU:IVAInventiva
      05/19/20224:00PMGlobeNewswire Inc.Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 19 May 2022EU:IVAInventiva
      05/19/20224:00PMGlobeNewswire Inc.Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 19 May 2022EU:IVAInventiva
      05/19/20224:00PMGlobeNewswire Inc.DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS AUTORISÉ PAR L'ASSEMBLÉE GÉNÉRALE ORDINAIRE DU 19 MAI 2022  EU:IVAInventiva
      05/16/20224:00PMGlobeNewswire Inc.Inventiva publie ses informations financières du 1er trimestre 2022 et fait un point sur ses développements cliniquesEU:IVAInventiva
      05/16/20224:00PMGlobeNewswire Inc.Inventiva reports 2022 First Quarter Financial Information and provides clinical development updateEU:IVAInventiva
      05/16/20224:00PMGlobeNewswire Inc.Inventiva reports 2022 First Quarter Financial Information and provides clinical development updateEU:IVAInventiva
      05/16/20222:00AMGlobeNewswire Inc.Inventiva obtient un crédit d’un montant de 50 millions d’euros de la part de la Banque Européenne d’InvestissementEU:IVAInventiva
      05/16/20222:00AMGlobeNewswire Inc.Inventiva secures a €50 million credit facility from the European Investment BankEU:IVAInventiva
       Showing the most relevant articles for your search:EU:IVA